Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy
Vaccine·
- DOI
- 10.1016/j.vaccine.2016.10.059
- PMID
- 27866768
- PMCID
- PMC10431197
- OpenAlex
- W2555296653
- Study type
- Journal article
- Publisher
- Elsevier BV
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The findings demonstrate endemic rubella virus transmission in the studied provinces and identify a substantial susceptible population among women of childbearing age, supporting the planned introduction of rubella-containing vaccine before 2020. The analysis guided recommendations for a catch-up campaign targeting children 9 months to 14 years and routine vaccination of women of childbearing age, aligned with World Health Organization guidance.
Structured evidence summary
Research question
The study aimed to estimate the burden of rubella virus infection and congenital rubella syndrome in the Democratic Republic of the Congo to inform rubella-containing vaccine introduction strategy.
Study design
Rubella antibody seroprevalence assessment using serum samples collected from pregnant women during 2008-2009. Catalytic models combined age- and site-specific seroprevalence estimates with population and fertility rates to estimate congenital rubella syndrome incidence and case counts for 2013.
Population and setting
The assessment included 1605 pregnant women aged 15-46 years attending 7 antenatal care sites across 3 provinces in the Democratic Republic of the Congo. Women from both urban and rural settings were represented.
Main findings
Overall, 84% of women tested were rubella antibody seropositive. Approximately 10-20% of women remained susceptible to rubella infection and at risk for having an infant with congenital rubella syndrome. The estimated national incidence of congenital rubella syndrome was 69 per 100,000 live births in 2013, corresponding to an estimated 2886 infants born with the syndrome. Seroprevalence varied by geographic area but not significantly by age or urban versus rural residence. Most rubella exposure and seroconversion occurred before age 15 years.
Public-health relevance
The findings demonstrate endemic rubella virus transmission in the studied provinces and identify a substantial susceptible population among women of childbearing age, supporting the planned introduction of rubella-containing vaccine before 2020. The analysis guided recommendations for a catch-up campaign targeting children 9 months to 14 years and routine vaccination of women of childbearing age, aligned with World Health Organization guidance.
Important limitations
The summary relies on the supplied single-article abstract and metadata. The abstract does not explicitly state study limitations such as potential selection bias from clinic-based sampling, representativeness of the 3 provinces for national estimates, or uncertainty in model parameters. Full interpretation requires access to the original paper.
GIDS interpretation
The article was classified under rubella, congenital rubella syndrome, Democratic Republic of the Congo, health policy, transmission dynamics, and vaccination topics. These tags support discoverability for users monitoring rubella epidemiology, vaccine policy development, and maternal-child health in Central Africa. The study provides baseline immunity data from a period before rubella-containing vaccine introduction.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 13 auditable classifier relationships to diseases, places, topics, and study design.